Cadila Healthcare
May 15, 2012 at 15:11 | Source: Moneycontrol.com
May 15, 2012 at 08:57 | Source: CNBC-TV18
May 11, 2012 at 18:09 | Source: Moneycontrol.com
May 10, 2012 at 14:36 | Source: Moneycontrol.com
May 10, 2012 at 09:51 | Source: CNBC-TV18
Apr 09, 2012 at 14:46 | Source: Moneycontrol.com
News across the web »
May 16, 2012 at 02:02 | Source: Economic Times
May 11, 2012 at 05:16 | Source: The Hindu BusinessLine
Apr 08, 2012 at 02:22 | Source: The Hindu BusinessLine
Mar 01, 2012 at 00:46 | Source: Business Standard
Feb 21, 2012 at 00:11 | Source: Business Standard
Interact & exchange stock tips & market info »
Related News »
Cadila Healthcare Ltd, a leading pharmaceutical company presents in formulation, active pharmaceutical ingredients, consumer wellness and animal health segments. The company launched 90 new products including over 40 line extensions of which 29 ...
May 16, 2012 at 04:40 | Source: equitybulls.com
Nirmal Bang has recommended hold rating on Cadila Healthcare (CHL) with a target price of Rs 831, in its May 11, 2012 research report. "After tepid performance in the 9MFY12 period, CHL’s domestic business has recovered in 4QFY12 and is likely ...
May 15, 2012 at 08:59 | Source: MoneyControl.com
Scope The report is an essential source of information on - - Analysis on the deal - Overall rationale of the deal - Financials - Company Profile of Abbott Laboratories and Zydus Cadila Healthcare Limited - Insights on the regulatory and development ...
May 17, 2012 at 08:42 | Source: CNBC
Cadila Healthcare (Cadila) reported lower-than-expected numbers for 4QFY2012, except on the sales front. The company's sales for the quarter were mostly in-line at Rs.1,344cr. On the operating front, gross and operating margins reported an ...
May 16, 2012 at 04:40 | Source: equitybulls.com
The outperformers have been Cadila Healthcare Ltd, Glenmark, GlaxoSmithKline and Pfizer. Cadila: The firm continues to show strong traction in acute and chronic segments, which is also reflected in its fourth quarter performance. Notably, respiratory ...
May 23, 2012 at 17:17 | Source: Livemint.com
Cadila Healthcare has posted disappointed performance during the year ended March 2011 due to significant rise in interest burden. Its consolidated net profit declined by 8.2 per cent to Rs.653 crore from Rs.711 crore in the previous year. Its EBDITA ...
May 10, 2012 at 10:02 | Source: pharmabiz.com
Law360, New York (May 11, 2012, 12:11 PM ET) -- Drug company Depomed Inc. lodged a patent infringement suit Wednesday in New Jersey in an effort to block plans by Indian drugmaker Cadila Healthcare Ltd. and its U.S. subsidiary to market a generic version ...
May 11, 2012 at 16:06 | Source: site.law360.com
On May 9, 2012, the Company filed a lawsuit in the United States District Court for the District of New Jersey against Zydus Pharmaceuticals (USA) Inc., ("Zydus Inc.") and Cadila Healthcare Limited ("Cadila") (collectively "Zydus") for infringement of U.S ...
May 18, 2012 at 10:14 | Source: Yahoo! Finance
filed 11 DMFs each and Cadila Healthcare Ltd and Lupin filed 10 DMFs during 2011. Other pharma majors like Macleods Pharmaceuticals submitted 9 DMFs with US FDA in 2011. Apotex Pharmachem India Pvt Ltd, Orchid Chemicals Ltd, Parabolic Drugs also filed 8 ...
May 21, 2012 at 02:25 | Source: pharmabiz.com
Cadila Healthcare is up nearly 2% at Rs 765 on posting healthy fourth quarter results. The market breadth continues to remain the negative. On the BSE, 1678 stocks declined as compared to 928 advances.
May 11, 2012 at 10:01 | Source: Business Standard